South Africa plans lenacapavir rollout amid TB drug gaps
By The BriefBrief
South Africa’s HIV prevention injection lenacapavir rollout depends on managing TB medicines that can reduce its effectiveness.
WHO:Researchers and health officials in South Africa
WHAT:Developing strategies to keep people protected on lenacapavir while addressing interactions with commonly used TB medicines
WHEN:Jun 29, 2026 at 5:43 PM ET
WHERE:South Africa
WHY:Some commonly used TB medicines reduce lenacapavir’s effectiveness, creating evidence gaps that need strategies to maintain HIV prevention protection.
Reporting from 1 identified publisher for this event.
